BC Cancer Kelowna uses 3D-printed applicators to improve cervical cancer radiation therapy accuracy and comfort.

A U.S. court blocked Edwards' $945M purchase of JenaValve over antitrust concerns, citing reduced competition in heart valve device markets.

Teva and Royalty Pharma partner to speed up a vitiligo treatment's development.

Healthcare stocks rise in early 2026 due to aging populations and medical innovation.

FDA grants breakthrough status to Ipsen’s drug for unfit acute myeloid leukemia.

LIR Life Sciences partners with Neuland Labs to develop non-injectable, patch-based obesity treatment using cell-penetrating peptides, backed by a $230,000 Phase 1 budget.

A new Swiss method tracks how antibiotics kill individual bacteria in real time, showing it better predicts treatment success than old tests.

AIIMS Raipur completes 100 robotic surgeries in four months, cutting recovery time and blood loss.

A new AI system, SleepFM, predicts over 130 diseases using one night of sleep data with high accuracy.

Starting Feb. 1, 2026, nitisinone for tyrosinemia type 1 and alkaptonuria will be publicly funded, simplifying access for about 10 patients.